Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Akiko Namba"'
Autor:
Tana Qian, Makoto Ooba, Minoru Fujii, Takanori Matsui, Chihiro Haga, Akiko Namba, Shogo Nakamura
Publikováno v:
Remote Sensing, Vol 16, Iss 4, p 706 (2024)
Forest biomass is expected to remain a key part of the national energy portfolio mix, yet residual forest biomass is currently underused. This study aimed to estimate the potential availability of waste woody biomass in the Aizu region and its energy
Externí odkaz:
https://doaj.org/article/4b0d170fbeef4674a324a1d5671ee6b0
Autor:
Toru Koda, Akiko Namba, Makoto Kinoshita, Yuji Nakatsuji, Tomoyuki Sugimoto, Kaori Sakakibara, Satoru Tada, Mikito Shimizu, Kazuya Yamashita, Kazushiro Takata, Teruyuki Ishikura, Syo Murata, Shohei Beppu, Atsushi Kumanogoh, Hideki Mochizuki, Tatsusada Okuno
Publikováno v:
Journal of Neuroinflammation, Vol 17, Iss 1, Pp 1-9 (2020)
Abstract Background Sema4A is a regulator of helper T cell (Th) activation and differentiation in the priming phase, which plays an important role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS). How
Externí odkaz:
https://doaj.org/article/d49d920b0c9e4ce0bb788c420d6efc2f
Autor:
Kazuya Yamashita, Makoto Kinoshita, Katsuichi Miyamoto, Akiko Namba, Mikito Shimizu, Toru Koda, Tomoyuki Sugimoto, Yuki Mori, Yoshichika Yoshioka, Yuji Nakatsuji, Atsushi Kumanogoh, Susumu Kusunoki, Hideki Mochizuki, Tatsusada Okuno
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-9 (2018)
Abstract Background Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease of the central nervous system. Although complement-dependent astrocyte damage mediated by anti-aquaporin 4 autoantibody (AQP4-Ab) is well acknowledged to be
Externí odkaz:
https://doaj.org/article/fafa388ac26149debb0a186a7f56c6b0
Autor:
Toru Koda, Akiko Namba, Yuji Nakatsuji, Masaaki Niino, Yusei Miyazaki, Tomoyuki Sugimoto, Makoto Kinoshita, Kazushiro Takata, Kazuya Yamashita, Mikito Shimizu, Toshiyuki Fukazawa, Atsushi Kumanogoh, Hideki Mochizuki, Tatsusada Okuno
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193986 (2018)
We previously demonstrated that patients with multiple sclerosis (MS) of high serum Sema4A levels are resistant to IFN-β therapy. To further elucidate the role of serum Sema4A as a biomarker for therapeutic stratification in MS patients, it is impor
Externí odkaz:
https://doaj.org/article/92f51c5e47454aee8d78c6c876acf4d7
Autor:
Josephe A Honorat, Yuji Nakatsuji, Mikito Shimizu, Makoto Kinoshita, Hisae Sumi-Akamaru, Tsutomu Sasaki, Kazushiro Takata, Toru Koda, Akiko Namba, Kazuya Yamashita, Eri Sanda, Manabu Sakaguchi, Atsushi Kumanogoh, Takashi Shirakura, Mizuho Tamura, Saburo Sakoda, Hideki Mochizuki, Tatsusada Okuno
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187215 (2017)
Oxidative stress and mitochondrial dysfunction are important determinants of neurodegeneration in secondary progressive multiple sclerosis (SPMS). We previously showed that febuxostat, a xanthine oxidase inhibitor, ameliorated both relapsing-remittin
Externí odkaz:
https://doaj.org/article/be680d76282241e49938ea77b2d4c654
Autor:
Yasuko Sugiyama, Kazushiro Takata, Makoto Kinoshita, Daisuke Motooka, Naoyuki Shiraishi, Keigo Kihara, Hisashi Murata, Shohei Beppu, Toru Koda, Kazuya Yamashita, Akiko Namba, Kosuke Fujimoto, Atsushi Kumanogoh, Tatsusada Okuno, Hideki Mochizuki
Publikováno v:
Biochemical and Biophysical Research Communications. 656:97-103
Autor:
Tana QIAN, Oba Makoto, Minoru Fujii, Takanori Matsui, Chihiro Haga, Akiko Namba, Shogo Nakamura
Publikováno v:
SSRN Electronic Journal.
Autor:
Satoru Tada, Eri Sanda, Kazushiro Takata, Kazuya Yamashita, Hideki Mochizuki, Toru Koda, Hisae Sumi-Akamaru, Akiko Namba, Tsutomu Sasaki, Makoto Kinoshita, Chi-Jing Choong, Tatsusada Okuno, Shigeru Miyagawa, Mikito Shimizu, Yuji Nakatsuji, Yoshiki Sawa, Yoshiki Sakai
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports
Scientific Reports
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by several pathologies including oxidative stress, apoptosis, neuroinflammation, and glutamate toxicity. Although multiple reports suggest that ischemia and
Autor:
Tatsusada Okuno, Kaori Sakakibara, Hideki Mochizuki, Satoru Tada, Kazuya Yamashita, Shohei Beppu, Teruyuki Ishikura, Akiko Namba, Makoto Kinoshita, Tomoyuki Sugimoto, Mikito Shimizu, Yuji Nakatsuji, Atsushi Kumanogoh, Kazushiro Takata, Syo Murata, Toru Koda
Publikováno v:
Journal of Neuroinflammation
Journal of Neuroinflammation, Vol 17, Iss 1, Pp 1-9 (2020)
Journal of Neuroinflammation, Vol 17, Iss 1, Pp 1-9 (2020)
Background Sema4A is a regulator of helper T cell (Th) activation and differentiation in the priming phase, which plays an important role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS). However, the
Autor:
Yoshichika Yoshioka, Yuki Mori, Tatsusada Okuno, Kazuya Yamashita, Hideki Mochizuki, Tomoyuki Sugimoto, Makoto Kinoshita, Toru Koda, Mikito Shimizu, Yuji Nakatsuji, Katsuichi Miyamoto, Akiko Namba, Susumu Kusunoki, Atsushi Kumanogoh
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-9 (2018)
Journal of Neuroinflammation
Journal of Neuroinflammation
Background Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease of the central nervous system. Although complement-dependent astrocyte damage mediated by anti-aquaporin 4 autoantibody (AQP4-Ab) is well acknowledged to be the core